In ccRCC, tumor progression is characterized by extensive collagen deposition and ECM stiffening, processes critically dependent on procollagen-lysine 2-oxoglutarate 5-dioxygenase (PLOD)-mediated collagen cross-linking modifications. Here, PLOD1 is linked to neoplasm.